Impilo Acquires Majority Stake in tandlægen.dk

KKR and Impilo Acquire Immedica Pharma

January 24, 2025

Pharmaceuticals

KKR and Nordic healthcare investor Impilo have completed a joint acquisition of Stockholm-based Immedica Pharma, with Immedica management reinvesting alongside the new owners. Immedica is a commercial-stage pharmaceutical company focused on rare and specialty diseases (notably hematology, oncology and genetic/metabolic disorders) with ~€100m revenue and more than 120 employees; CVC Credit provided debt financing and Impilo used a single-asset continuation fund supported by secondary investors.

Orkla Health Acquires NutraQ from Impilo

June 15, 2021

E-Commerce

On 15 June 2021 Orkla Health completed the acquisition of NutraQ from Nordic private equity owner Impilo. NutraQ is a Norway-founded, subscription-based D2C health and wellness platform that expanded across the Nordics under Impilo and delivered strong revenue and earnings growth. Orkla said the deal will help accelerate NutraQ's geographic expansion and growth across new product categories.

Solmetex, LLC Acquires Impladent Ltd.

June 5, 2023

Dental

Solmetex, LLC acquired Impladent Ltd., a provider of regenerative dental materials including bone grafts and resorbable membranes, to expand its dental product portfolio. The transaction — supported by Solmetex's existing investor Avista Capital Partners — brings nearly 40 years of Impladent expertise into the Solmetex platform; financial terms were not disclosed.

Thomas H. Lee Partners and Linden Capital Partners Invest in Smile Doctors

January 5, 2022

Healthcare Services

Smile Doctors, the largest U.S. orthodontics-focused dental support organization with more than 295 locations, announced a strategic investment from Thomas H. Lee Partners. THL is investing alongside existing sponsor Linden Capital Partners in an equal partnership while affiliated orthodontists retain a significant ownership stake to support continued growth and expanded service offerings.

BlackRock LTPC Acquires Majority Stake in Paradigm Oral Health

September 22, 2022

Healthcare Services

BlackRock Long Term Private Capital (LTPC) has entered into a definitive agreement to acquire a majority interest in Paradigm Oral Health from shareholders including InTandem Capital Partners. The investment will partner with Paradigm's executive team, led by founder and CEO Dr. David Rallis, to support platform expansion, technology adoption and continued growth of the company's oral surgery and digital dentistry platform.

Proclinic Group (backed by Miura Partners) Acquires Cenger Scandinavia

September 4, 2025

Medical Devices

Proclinic Group, a European dental platform backed by Miura Partners, has acquired Cenger Scandinavia, a leading dental distributor in Denmark with more than 1,300 clients and the number one distributor in the dental laboratory segment. The acquisition marks Proclinic Group's entry into the Nordic market and is intended to expand the Group's European footprint, enhance its service offering for dental professionals, and generate commercial synergies in the region.